MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection

Current Opinion in HIV and AIDS

Volumn 9, Issue 5, 2014, Pages 464-471

  Swaminathan, Sanjay ^a,b,c   Kelleher, Anthony D ^d,e  

^a BLACKTOWN HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d St Vincent's Centre for Applied Medical Research   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

HIV 1; microRN

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD4 ANTIGEN; INTERLEUKIN 10; LET 7 MICRORNA; MICRORNA; MICRORNA 9; UNCLASSIFIED DRUG;

BIOGENESIS; CD4+ T LYMPHOCYTE; EXHAUSTION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REDUCTION; REVIEW; RNA PROCESSING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE EXHAUSTION; VIRUS PATHOGENESIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; MICRORNAS;

EID: 84906055919     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000089     Document Type: Review

References (57)

1. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136:215-233.
2. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011; 91:827-887.
3. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009; 9:703-711.
4. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-10518.
5. Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007; 315:1579-1582. (Pubitemid 46449475)
6. Swaminathan S, Murray DD, Kelleher AD. miRNAs and HIV: Unforeseen determinants of host-pathogen interaction. Immunol Rev 2013; 254:265-280.
7. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
8. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14:1902-1910. (Pubitemid 39386503)
9. Kim YK, Kim VN. Processing of intronic microRNAs. EMBO J 2007; 26:775-783.
10. Van Wynsberghe PM, Kai ZS, Massirer KB, et al. LIN-28 co-transcriptionally binds primary let-7 to regulate miRNA maturation in Caenorhabditis elegans. Nat Struct Mol Biol 2011; 18:302-308.
11. Corcoran DL, Pandit KV, Gordon B, et al. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One 2009; 4:e5279.
12. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006; 13:1097-1101. (Pubitemid 44885920)
13. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23:4051-4060. (Pubitemid 39472426)
14. Han J, Lee Y, Yeom KH, et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004; 18:3016-3027. (Pubitemid 39658171)
15. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-419. (Pubitemid 37187272)
16. Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science 2004; 303:95-98. (Pubitemid 38055779)
17. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409:363-366. (Pubitemid 32151243)
18. Trabucchi M, Briata P, Garcia-Mayoral M, et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009; 459:1010-1014.
19. Sheth U, Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003; 300:805-808. (Pubitemid 36532117)
20. Bronevetsky Y, Villarino AV, Eisley CJ, et al. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J Exp Med 2013; 210:417-432.
21. Jeker LT, Bluestone JA. MicroRNA regulation of T-cell differentiation and function. Immunol Rev 2013; 253:65-81.
22. Dooley J, Linterman MA, Liston A. MicroRNA regulation of T-cell development. Immunol Rev 2013; 253:53-64.
23. Gallimore A, Glithero A, Godkin A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998; 187:1383-1393. (Pubitemid 28215398)
24. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188:2205-2213. (Pubitemid 29028493)
25. Wherry EJ. T cell exhaustion. Nat Immunol 2011; 12:492-499.
26. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354. (Pubitemid 44435155)
27. Seddiki N, Phetsouphanh C, Swaminathan S, et al. The microRNA-9/ Blymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection. Eur J Immunol 2013; 43:510-520.
28. Gong D, Malek TR. Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J Immunol 2007; 178:242-252. (Pubitemid 46033607)
29. Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008; 26:133-169. (Pubitemid 351600373)
30. Thiele S, Wittmann J, Jack HM, Pahl A. miR-9 enhances IL-2 production in activated human CD4(\+) T cells by repressing Blimp-1. Eur J Immunol 2012; 42:2100-2108.
31. Brockman MA, Kwon DS, Tighe DP, et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009; 114:346-356.
32. Swaminathan S, Suzuki K, Seddiki N, et al. Differential regulation of the Let-7 family of microRNAs in CD4\+ T cells alters IL-10 expression. J Immunol 2012; 188:6238-6246.
33. Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4\+ T lymphocytes. Nat Med 2007; 13:1241-1247. (Pubitemid 47530631)
34. Mantri CK, Mantri JV, Pandhare J, Dash C. Methamphetamine inhibits HIV-1 replication in CD4\+ T cells by modulating anti-HIV-1 miRNA expression. Am J Pathol 2014; 184:92-100.
35. Bignami F, Pilotti E, Bertoncelli L, et al. Stable changes in CD4\+ T lymphocyte miRNA expression after exposure to HIV-1. Blood 2012; 119:6259-6267.
36. Seddiki N, Swaminathan S, Phetsouphanh C, Kelleher AD. miR-155 is differentially expressed in Treg subsets, which may explain expression level differences of miR-155 in HIV-1 infected patients. Blood 2012; 119:6396-6397.
37. Ahluwalia JK, Khan SZ, Soni K, et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008; 5:117.
38. Nathans R, Chu CY, Serquina AK, et al. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 2009; 34:696-709.
39. Hariharan M, Scaria V, Pillai B, Brahmachari SK. Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 2005; 337:1214-1218. (Pubitemid 41505253)
40. Chiang K, Liu H, Rice AP. miR-132 enhances HIV-1 replication. Virology 2013; 438:1-4.
41. Cullen BR. Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev 2011; 25:1881-1894.
42. Omoto S, Ito M, Tsutsumi Y, et al. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 2004; 1:44.
43. Lin J, Cullen BR. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 2007; 81:12218-12226. (Pubitemid 350085837)
44. Pfeffer S, Sewer A, Lagos-Quintana M, et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2005; 2:269-276. (Pubitemid 41131008)
45. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005; 22:607-619. (Pubitemid 40719196)
46. Cullen BR. Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 2006; 7:563-567. (Pubitemid 43797336)
47. Klase Z, Kale P, Winograd R, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 2007; 8:63.
48. Ouellet DL, Plante I, Landry P, et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 2008; 36:2353-2365. (Pubitemid 351567008)
49. Klase Z, Winograd R, Davis J, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 2009; 6:18.
50. Ouellet DL, Vigneault-Edwards J, Letourneau K, et al. Regulation of host gene expression by HIV-1 TAR microRNAs. Retrovirology 2013; 10:86.
51. Zhang Y, Fan M, Geng G, et al. A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region. Retrovirology 2014; 11:23.
52. Schopman NC, Willemsen M, Liu YP, et al. Deep sequencing of virus-infected cells reveals HIV-encoded smallRNAs. Nucleic Acids Res 2012; 40:414-427.
53. Althaus CF, Vongrad V, Niederost B, et al. Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells. Retrovirology 2012; 9:27.
54. Whisnant AW, Bogerd HP, Flores O, et al. In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio 2013; 4:e000193.
55. Wan YW, Mach CM, Allen GI, et al. On the reproducibility of TCGA ovarian cancer microRNA profiles. PLoS One 2014; 9:e87782.
56. Hwang HW, Wentzel EA, Mendell JT. Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci USA 2009; 106:7016-7021.
57. Barbato C, Arisi I, Frizzo ME, et al. Computational challenges in miRNA target predictions: To be or not to be a true target? J Biomed Biotechnol 2009; 2009:803069.